U
IHE icon

UBS’s iShares US Pharmaceuticals ETF IHE Stock Holding History

UBS’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$4.82M Sell
102,984
-73,353
-42% -$3.31M ﹤0.01% 2073
2014
Q2 		$7.94M Buy
176,337
+12,933
+8% +$556K 0.01% 1549
2014
Q1 		$6.9M Buy
163,404
+22,680
+16% +$951K 0.01% 1550
2013
Q4 		$5.54M Buy
140,724
+36,441
+35% +$1.37M 0.01% 1769
2013
Q3 		$3.7M Buy
104,283
+6,171
+6% +$217K ﹤0.01% 1983
2013
Q2 		$3.26M Buy
+98,112
New +$3.26M ﹤0.01% 2022

Other funds holding IHE

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS's IHE Position: Q3 2014 in Review

UBS reduced its iShares US Pharmaceuticals ETF (IHE) stake by 42% in Q3 2014, selling an estimated $3.31M and leaving 102,984 shares worth $4.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

UBS first reported a position in IHE in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.94M in Q2 2014. 86 funds tracked by Wall St. Rank hold IHE as of Q3 2014.

  • UBS held 102,984 shares of iShares US Pharmaceuticals ETF worth $4.82M as of Q3 2014.
  • UBS sold 73,353 iShares US Pharmaceuticals ETF shares in Q3 2014, an estimated $3.31M.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2073 holding.
  • UBS first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 6 quarters since.
  • UBS's iShares US Pharmaceuticals ETF position peaked at $7.94M in Q2 2014.
  • 86 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.